JOURNAL OF ONCOLOGY PHARMACY PRACTICE

Scope & Guideline

Connecting research and practice in the fight against cancer.

Introduction

Explore the comprehensive scope of JOURNAL OF ONCOLOGY PHARMACY PRACTICE through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore JOURNAL OF ONCOLOGY PHARMACY PRACTICE in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1078-1552
PublisherSAGE PUBLICATIONS LTD
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1995 to 2024
AbbreviationJ ONCOL PHARM PRACT / J. Oncol. Pharm. Pract.
Frequency8 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND

Aims and Scopes

The JOURNAL OF ONCOLOGY PHARMACY PRACTICE focuses on optimizing pharmaceutical care in oncology, emphasizing the intersection of pharmacotherapy, patient safety, and clinical practice within cancer care. The journal aims to improve patient outcomes by disseminating research that addresses medication management, adverse drug reactions, and innovative pharmacy practices in oncology settings.
  1. Pharmaceutical Care in Oncology:
    The journal emphasizes the role of pharmacists in providing comprehensive medication management, ensuring safe and effective use of anticancer therapies, and enhancing patient education.
  2. Adverse Drug Reactions and Toxicity Management:
    Research on the identification, prevention, and management of adverse drug reactions related to cancer therapies, focusing on improving patient safety and quality of life.
  3. Clinical Pharmacy Interventions:
    The journal highlights studies on clinical pharmacy interventions, including medication reconciliation, therapeutic drug monitoring, and the integration of clinical pharmacists in oncology teams.
  4. Pharmacotherapy Research:
    The focus includes pharmacotherapy outcomes, including efficacy and safety of various cancer treatments, comparative effectiveness studies, and advancements in drug regimens.
  5. Patient-Centered Care:
    Research related to patient experience, adherence to medication, and the impact of educational interventions on cancer patients' knowledge and management of their therapies.
  6. Innovative Pharmacy Practices:
    Exploration of new methodologies in pharmacy practice, including the use of technology, telepharmacy, and automation in medication management for oncology patients.
The JOURNAL OF ONCOLOGY PHARMACY PRACTICE has increasingly shifted its focus towards emerging themes that reflect current challenges and advancements in oncology pharmacy. This trend showcases the journal's commitment to addressing contemporary issues in cancer care.
  1. Immunotherapy and Targeted Therapies:
    There is a growing emphasis on research related to immunotherapy and targeted therapies, reflecting their increasing use and complexity in cancer treatment.
  2. Pharmacogenomics and Personalized Medicine:
    Research into pharmacogenomics is on the rise, focusing on how genetic variations affect patient responses to cancer medications, promoting personalized treatment strategies.
  3. Telepharmacy and Remote Care:
    The incorporation of telepharmacy in oncology has gained traction, particularly in light of the COVID-19 pandemic, facilitating remote patient monitoring and medication management.
  4. Patient Education and Engagement:
    An increased focus on the importance of patient education and engagement strategies that enhance adherence and understanding of treatment protocols is evident.
  5. Management of Adverse Effects:
    Emerging research is increasingly centered on strategies to manage and mitigate adverse effects associated with modern cancer therapies, including immune-related adverse events.
  6. Cost-Effectiveness Studies:
    There is an upward trend in studies assessing the economic impact of cancer therapies, emphasizing the need for cost-effective treatment options in oncology.

Declining or Waning

In recent years, certain themes within the JOURNAL OF ONCOLOGY PHARMACY PRACTICE have seen a decline in focus, likely reflecting shifts in research priorities and emerging trends in oncology pharmacy practice.
  1. Traditional Chemotherapy Protocols:
    Research focused specifically on traditional chemotherapy regimens appears to be declining as newer targeted therapies and immunotherapies gain prominence.
  2. Single-Agent Studies:
    There is a noticeable decrease in publications centered on single-agent chemotherapy studies, as multi-agent and combination therapies become the focus of clinical research.
  3. Pharmacy Practice Guidelines:
    While guidelines remain important, there is a shift away from generic pharmacy practice guidelines towards more specific, evidence-based protocols tailored to individual patient needs.
  4. Focus on Pharmacokinetics Alone:
    Research that solely emphasizes pharmacokinetic studies without considering pharmacodynamics and clinical outcomes has seen less attention as a more holistic approach gains traction.
  5. Limited Scope on Complementary Therapies:
    Interest in complementary and alternative medicine approaches in oncology has waned, with a stronger emphasis on evidence-based pharmacotherapy.

Similar Journals

Journal of Research in Pharmacy Practice

Bridging research and practice for better healthcare outcomes.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 2319-9644Frequency: 4 issues/year

Journal of Research in Pharmacy Practice, published by WOLTERS KLUWER MEDKNOW PUBLICATIONS, is a premier open-access journal dedicated to advancing the field of pharmaceutical sciences through rigorous research and innovative practices. Since its inception, the journal has aimed to bridge gaps between pharmacy practice and research, providing a platform for researchers, professionals, and students alike to disseminate their findings and insights. With a commitment to high-quality, peer-reviewed content, the journal covers a wide array of topics including clinical pharmacy, medication management, and healthcare policies, contributing to the enhancement of global healthcare practices. The journal is easily accessible online, having embraced an open-access model since 2012, ensuring that valuable research is freely available to all. Engaging with the Journal of Research in Pharmacy Practice not only facilitates knowledge exchange but also aids in the continuous evolution of pharmacy practice, emphasizing its critical role in healthcare delivery and patient outcomes.

HOSPITAL PHARMACY

Empowering healthcare with evidence-based pharmacy insights.
Publisher: SAGE PUBLICATIONS INCISSN: 0018-5787Frequency: 6 issues/year

Hospital Pharmacy is a distinguished journal published by SAGE Publications Inc., dedicated to advancing the field of pharmacy practice within health professions. Established in 1973 and with a commitment to scholarly excellence extending to 2024, the journal aims to provide a platform for research that impacts patient care and medication management. With an impact factor that reflects its contribution to the field, it holds a notable position in Pharmacology and Pharmacy, ranking in the Q3 category in both pharmacology domains and Q2 in the pharmacy category as of 2023. The journal’s commitment to evidence-based practice is evident through its rigorous publication standards, making it an essential resource for researchers, practitioners, and students alike. Though it operates under a subscription model, its vast repository of knowledge facilitates significant advancements in pharmaceutical sciences and clinical pharmacy practices. For those engaged in the healthcare sector, Hospital Pharmacy serves not only as a source of research but also as a catalyst for innovative practices in the pharmacy profession.

Journal of Pharmaceutical Policy and Practice

Advancing pharmaceutical insights for better health outcomes.
Publisher: TAYLOR & FRANCIS LTDISSN: Frequency: 1 issue/year

Journal of Pharmaceutical Policy and Practice, published by Taylor & Francis Ltd, is a premier open access journal dedicated to advancing the field of pharmaceutical policy and practice. Launched in 2013, this esteemed journal has rapidly become a vital resource for researchers, practitioners, and policymakers alike, offering a critical examination of health policies and their implementation in pharmaceutical contexts. With an impressive impact factor reflecting its significance, it ranks in the Q2 category for Health Policy and Q1 in both Pharmacology, Toxicology and Pharmaceutics and Pharmacy, showcasing its high-quality contributions to the field. Accessible to a global audience since 2014, the journal disseminates innovative research findings that inform best practices, foster policy development, and enhance patient outcomes in the pharmaceutical landscape. Positioned in the UK and with strong Scopus rankings, specifically ranked #3 in Health Professions (Pharmacy), the journal serves as an essential platform for those striving to navigate the ever-evolving intersection of healthcare and pharmaceutical sciences.

Journal of Pharmacy and Bioallied Sciences

Pioneering Discoveries in Pharmacy and Bioallied Fields
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0976-4879Frequency: 6 issues/year

The Journal of Pharmacy and Bioallied Sciences is a premier open access publication that has been contributing to the fields of Pharmacy, Bioengineering, and Biochemistry since its establishment in India, under the esteemed Wolters Kluwer Medknow Publications. With the ISSN 0976-4879 and E-ISSN 0975-7406, this journal provides a platform for high-quality research articles, reviews, and clinical studies aimed at advancing knowledge and practice in the pharmaceutical and allied sciences. As a reflection of its academic stature, the journal holds a respectable categorization within the third and fourth quartiles in pertinent fields according to the latest metrics, with rankings that place it among prominent emerging research in pharmacology and biochemistry. Researchers and professionals are encouraged to access a wealth of knowledge freely, as the journal has been open access since 2010. The journal not only aims to foster innovative research but also strives to bridge the gap between pharmaceutical sciences and real-world applications, making it an essential resource for students, academics, and industry experts alike.

International Journal of Clinical Pharmacy

Elevating Clinical Practices with Groundbreaking Findings
Publisher: SPRINGERISSN: 2210-7703Frequency: 6 issues/year

The International Journal of Clinical Pharmacy, published by Springer, serves as a pivotal platform for advancing research in the fields of Pharmaceutical Science and Pharmacology. This esteemed journal, recognized for its significant impact with an impressive Q1 ranking in Pharmacy and multiple Q2 designations, provides a dedicated space for scholars and practitioners to share innovative findings and methodologies that enhance clinical pharmacy practices. With an international reach and publication spanning from 2011 to 2024, the journal aims to facilitate knowledge exchange among researchers, professionals, and students, ultimately contributing to improved therapeutic outcomes. As an open-access journal, it promotes widespread dissemination of vital research, ensuring that cutting-edge clinical pharmacy knowledge is accessible to all stakeholders in the healthcare continuum.

JOURNAL OF PHARMACY PRACTICE AND RESEARCH

Championing advancements in pharmacy and pharmacology.
Publisher: WILEYISSN: 1445-937XFrequency: 6 issues/year

JOURNAL OF PHARMACY PRACTICE AND RESEARCH is a pivotal platform dedicated to advancing knowledge and practice in the fields of pharmacy and pharmacology. Published by WILEY, this journal boasts a commendable impact factor, reflecting its contribution to the scientific community. With an ISSN of 1445-937X and E-ISSN 2055-2335, it emphasizes high-quality, peer-reviewed research essential for pharmacists, healthcare professionals, and researchers. Operating without an open-access model, it currently holds a Q3 ranking in Pharmacology and a Q2 ranking in Pharmacy according to the 2023 category quartiles, positioning it as a key resource for evidence-based practices and recent innovations in the pharmaceutical sciences. The journal spans from 2002 to 2024 and is recognized for enhancing the dialogue between academia and clinical practice. It provides a vital portal for exploring contemporary research trends and addressing pressing challenges in pharmacy practice, making it an indispensable resource for advancing professional development and improving patient care.

Integrated Pharmacy Research and Practice

Uniting research and practice to elevate pharmaceutical standards.
Publisher: DOVE MEDICAL PRESS LTDISSN: 2230-5254Frequency: 1 issue/year

Integrated Pharmacy Research and Practice is a peer-reviewed, open-access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the field of pharmacy through innovative research and practice. With its ISSN 2230-5254, the journal has been providing a vital platform for disseminating new findings and best practices since its inception in 2012. Targeting researchers, practitioners, and students alike, it encompasses a broad scope that includes clinical pharmacy, drug regulation, and the socio-economic impact of pharmacy practices. Positioned in New Zealand's vibrant academic landscape, the journal aims to foster collaboration and knowledge sharing among professionals while upholding rigorous standards of scientific integrity. By offering unrestricted access to its content, Integrated Pharmacy Research and Practice plays a crucial role in shaping the future of pharmaceutical sciences and enhancing patient care globally.

JOURNAL OF PHARMACY PRACTICE

Transforming medication management through scholarly excellence.
Publisher: SAGE PUBLICATIONS INCISSN: 0897-1900Frequency: 6 issues/year

JOURNAL OF PHARMACY PRACTICE, published by SAGE PUBLICATIONS INC, is a vital resource for researchers, pharmacy practitioners, and students dedicated to advancing the pharmacological and pharmaceutical sciences. Established in 1988, the journal serves as a platform for original research, reviews, and critical analyses in the fields of pharmacy and pharmacology. With an impressive impact factor and a strong presence in the Q2 category in Pharmacy and Q3 in Pharmacology (medical) as of 2023, it reflects the journal's commitment to delivering high-quality scholarly content that addresses pressing issues in pharmacy practice and medication management. The journal is indexed in Scopus, ranking #154 out of 272 in the field of Medicine and Pharmacology, positioning it within the 43rd percentile. Although it currently does not offer open access options, it remains an essential publication for those seeking to stay updated on innovations and best practices in the pharmacy sector, making it an indispensable tool for academic and professional growth.

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Elevating standards in clinical pharmacy and patient care.
Publisher: WILEY-HINDAWIISSN: 0269-4727Frequency: 1 issue/year

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, an esteemed publication in the field of pharmacology, is published by Wiley-Hindawi and has been at the forefront of clinical research since its inception in 1976. Operating primarily from the United Kingdom, this journal features a diverse array of articles that encompass both fundamental and practical aspects of clinical pharmacy, thereby supporting the advancement of therapeutic practices. With an ISSN of 0269-4727 and an E-ISSN of 1365-2710, it is indexed in key databases and holds respectable ranks within its categories; achieving Q3 in Pharmacology and Q2 in Medical Pharmacology in the latest quartile rankings. Its Scopus ranking reflects both its quality and relevance, being positioned in the 55th percentile for medical pharmacology and the 45th for pharmacology, toxicology, and pharmaceutics. Although it does not currently operate under an Open Access model, the journal's extensive readership and rigorous peer-review process ensure that the latest research reaches practitioners and academics alike. With a commitment to bridging the gap between pharmacological science and clinical practice, the JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS remains a critical resource for professionals striving to enhance patient outcomes through informed medication management.

Exploratory Research in Clinical and Social Pharmacy

Empowering healthcare professionals with groundbreaking findings.
Publisher: ELSEVIERISSN: Frequency: 4 issues/year

Exploratory Research in Clinical and Social Pharmacy is a leading peer-reviewed journal published by Elsevier, dedicated to advancing knowledge and research in the field of pharmacy and its intersection with clinical and social dimensions. Since its inception in 2021, the journal has carved out an essential niche in the academic community, as reflected by its strong impact factor and reputable category rankings, including Q3 in Health, Toxicology and Mutagenesis, Q3 in Pharmacology (Medical), and Q1 in Pharmacy as of 2023. The journal aims to disseminate innovative research findings, case studies, and reviews that address contemporary challenges and solutions within the pharmacy discipline, making it a vital resource for researchers, healthcare professionals, and students alike. With its emphasis on open access, Exploratory Research in Clinical and Social Pharmacy is committed to promoting inclusive and widespread expertise within the field, facilitating collaboration and knowledge transfer across global audiences. For its readers, this journal promises to be an invaluable tool for staying updated with the latest trends and advancements in pharmacy practice and research.